Craft
  • Home
  •  / Osiris Therapeutics
Osiris Therapeutics

Osiris Therapeutics

Revenue

$142.8 M

FY, 2018

Osiris Therapeutics Summary

Company summary

Overview
Osiris Therapeutics is a company that researches, develops, manufactures, markets, and distributes regenerative medicine products. Its product Grafix is a cryopreserved placental membrane for treating acute and chronic wounds, venous leg ulcers, and burns. In addition, the company offers BIO4, a bone allograft for use in all surgical applications, including spine, trauma, extremity, cranial, and foot and ankle surgery, and Cartiform, a viable chondral allograft that promotes articular cartilage repair to treat focal chondral defects.
Type
Subsidiary
Founded
1992
HQ
Columbia, MD, US | view all locations
Website
http://osiris.com
Cybersecurity rating
Sectors

LocationsView all

1 location detected

  • Columbia, MD HQ

    United States

    7015 Albert Einstein Dr

Osiris Therapeutics Financials

Summary financials

Revenue (FY, 2018)
$142.8M
Gross profit (FY, 2018)
$104.7M
Net income (FY, 2018)
$36.9M
Cash (FY, 2018)
$16.4M
EBIT (FY, 2018)
$9.9M

Footer menu